These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20414048)

  • 1. The malarial metabolite hemozoin and its potential use as a vaccine adjuvant.
    Coban C; Yagi M; Ohata K; Igari Y; Tsukui T; Horii T; Ishii KJ; Akira S
    Allergol Int; 2010 Jun; 59(2):115-24. PubMed ID: 20414048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between malaria parasites and the host immune system.
    Engwerda CR; Good MF
    Curr Opin Immunol; 2005 Aug; 17(4):381-7. PubMed ID: 15950450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing immune responses against Plasmodium for rational vaccine design.
    Douradinha B; Doolan DL
    Trends Parasitol; 2011 Jun; 27(6):274-83. PubMed ID: 21531627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathological effects of malaria pigment or hemozoin and other crystals.
    Tyberghein A; Deroost K; Schwarzer E; Arese P; Van den Steen PE
    Biofactors; 2014; 40(1):59-78. PubMed ID: 23907956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune evasion by malaria parasites: a challenge for vaccine development.
    Casares S; Richie TL
    Curr Opin Immunol; 2009 Jun; 21(3):321-30. PubMed ID: 19493666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate inflammatory response to the malarial pigment hemozoin.
    Shio MT; Kassa FA; Bellemare MJ; Olivier M
    Microbes Infect; 2010 Nov; 12(12-13):889-99. PubMed ID: 20637890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design.
    Taylor-Robinson AW
    Exp Parasitol; 2010 Nov; 126(3):406-14. PubMed ID: 20138874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors.
    Nebl T; De Veer MJ; Schofield L
    Parasitology; 2005; 130 Suppl():S45-62. PubMed ID: 16281992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemozoin in Malarial Complications: More Questions Than Answers.
    Pham TT; Lamb TJ; Deroost K; Opdenakker G; Van den Steen PE
    Trends Parasitol; 2021 Mar; 37(3):226-239. PubMed ID: 33223096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
    Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
    Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological processes in malaria pathogenesis.
    Schofield L; Grau GE
    Nat Rev Immunol; 2005 Sep; 5(9):722-35. PubMed ID: 16138104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A perspective on malaria vaccines.
    Desowitz RS; Miller LH
    Bull World Health Organ; 1980; 58(6):897-908. PubMed ID: 6783333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of synthetic hemozoin adjuvant: A preliminary safety evaluation.
    Lee MS; Igari Y; Tsukui T; Ishii KJ; Coban C
    Vaccine; 2016 Apr; 34(18):2055-61. PubMed ID: 26976665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria: immune evasion by parasites.
    Hisaeda H; Yasutomo K; Himeno K
    Int J Biochem Cell Biol; 2005 Apr; 37(4):700-6. PubMed ID: 15694829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9.
    Coban C; Igari Y; Yagi M; Reimer T; Koyama S; Aoshi T; Ohata K; Tsukui T; Takeshita F; Sakurai K; Ikegami T; Nakagawa A; Horii T; Nuñez G; Ishii KJ; Akira S
    Cell Host Microbe; 2010 Jan; 7(1):50-61. PubMed ID: 20114028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.
    Taylor-Robinson AW
    Expert Rev Vaccines; 2002 Oct; 1(3):317-40. PubMed ID: 12901572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case for whole-parasite malaria vaccines.
    Wykes M; Good MF
    Int J Parasitol; 2007 Jun; 37(7):705-12. PubMed ID: 17408673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical model for optimal use of sulfadoxine-pyrimethamine as a temporary malaria vaccine.
    Dembele B; Friedman A; Yakubu AA
    Bull Math Biol; 2010 May; 72(4):914-30. PubMed ID: 19908101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Malaria Vaccine Epidemiology and Evaluation Project of Papua New Guinea: rationale and baseline studies.
    Alpers MP; al-Yaman F; Beck HP; Bhatia KK; Hii J; Lewis DJ; Paru R; Smith TA
    P N G Med J; 1992 Dec; 35(4):285-97. PubMed ID: 1341090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria vaccines.
    Gordon DM
    Infect Dis Clin North Am; 1990 Jun; 4(2):299-313. PubMed ID: 2189001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.